Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Krystal S. Bottom"'
Autor:
Krystal S. Bottom, David M. Ashley, Henry S. Friedman, Darryl C. Longee, Albert Moghrabi, Joanne Kurtzberg, Elizabeth Stewart, Tracy Kerby, Jennifer Lawyer, Margaret Duncan-Brown, Janis Ryan, Melody Watral, Mary Parry
Publikováno v:
Journal of Neuro-Oncology. 46:151-156
Cyclophosphamide is an alkylating agent that has shown activity in the treatment of pediatric brain tumors, including high-grade gliomas. This study was designed to evaluate the response of patients with newly diagnosed glioblastoma multiforme to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d043809e6082ffae14a5d5149ecf49b6
https://doi.org/10.1023/a:1006258026274
https://doi.org/10.1023/a:1006258026274
Publikováno v:
Journal of Pediatric Hematology/Oncology. 19:73-76
PURPOSE Sodium valproate is commonly used as an anticonvulsant for patients with refractory epilepsy. Hematopoietic toxicity involving platelets or erythrocytes has been previously described, as well as a few cases of generalized bone marrow suppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c728ec6d4dd53d07d870e6fbbc40cba
https://doi.org/10.1097/00043426-199701000-00011
https://doi.org/10.1097/00043426-199701000-00011
Autor:
Melody A. Watral, Elizabeth A. Stewart, Martin A. Champagne, Krystal S. Bottom, Karima Rasheed, Albert Moghrabi, Darryl C. Longee, Janis Ryan, Roger E. McLendon, Linda Hershon, Tracy Kerby, Henry S. Friedman, Timothy M. George, Carol S. Bruggers, David N. Korones, James M. Provenzale, Allan H. Friedman, Herbert E. Fuchs, Edward G. Buckley, David M. Ashley, Shelley Lovell
Publikováno v:
Neurosurgical focus. 4(4)
In this study, the authors sought to investigate the response rate and toxicity of carboplatin in patients with progressive low-grade glioma (LGG). Thirty-two patients with progressive LGG were treated with carboplatin at a dosage of 560 mg/m2. Treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e4f5bbd414b537d550df53c57e6aaf
https://pubmed.ncbi.nlm.nih.gov/17168503
https://pubmed.ncbi.nlm.nih.gov/17168503
Autor:
Sridharan Gururangan, Sandra Tourt-Uhlig, Rodney Beason, Krystal S. Bottom, Allan H. Friedman, Roger E. McLendon, Melody A. Watral, Christopher D. Turner, Langdon L. Miller, Henry S. Friedman, James D. Eastwood
A phase II study of irinotecan (CPT-11) was conducted at Duke University Medical Center, Durham, NC, to evaluate the activity of this agent in children with high-risk malignant brain tumors. A total of 22 children were enrolled in this study, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a35f4283061fd2388891c3da0a3243
https://europepmc.org/articles/PMC1920653/
https://europepmc.org/articles/PMC1920653/
